Skip to main content
Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
22.24
+0.24 (1.09%)
At close: Mar 9, 2026, 4:00 PM EDT
22.16
-0.08 (-0.36%)
After-hours: Mar 9, 2026, 5:47 PM EDT

Pacira BioSciences Revenue

In the year 2025, Pacira BioSciences had annual revenue of $726.41M with 3.63% growth. Pacira BioSciences had revenue of $196.87M in the quarter ending December 31, 2025, with 5.14% growth.

Revenue (ttm)
$726.41M
Revenue Growth
+3.63%
P/S Ratio
1.22
Revenue / Employee
$876,250
Employees
829
Market Cap
900.50M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025726.41M25.45M3.63%
Dec 31, 2024700.97M25.99M3.85%
Dec 31, 2023674.98M8.16M1.22%
Dec 31, 2022666.82M125.29M23.14%
Dec 31, 2021541.53M111.89M26.04%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perrigo Company 4.25B
Evotec SE 887.40M
Tilray Brands 837.32M
Collegium Pharmaceutical 780.57M
Amphastar Pharmaceuticals 719.89M
Alvotech 573.35M
Esperion Therapeutics 303.80M
Ironwood Pharmaceuticals 296.15M
Revenue Rankings

PCRX News

More News